Wall Street Journal -- NEW YORK (Dow Jones)--Ironwood Pharmaceuticals Inc. (IRWD) and Forest Laboratories Inc. (FRX) reported the success of their drug linaclotide in treating irritable bowel syndrome with constipation, in the second of two late-stage trials of the drug.
